Search

everythinglearnresearchcommunity

for

Search:↓

Isotretinoin can effectively reduce symptoms of frontal fibrosing alopecia.

Minoxidil helps with hair regrowth in women with androgenic alopecia.

1 mg/day oral finasteride significantly improves hair growth in men with male pattern baldness.

Minoxidil and finasteride are promising drugs that can prevent hair loss and promote new growth in people with common hair loss condition.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Levothyroxine is less effective in men with early-onset male-pattern baldness.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Nanocarrier-based treatments show promise for better hair growth in androgenetic alopecia but need more research.

Oral contraceptive use may increase the risk of frontal fibrosing alopecia in women with a specific CYP1B1 gene variant.

Oral finasteride seems more effective for hair loss in postmenopausal women, but more research is needed.

Genetic factors could lead to personalized treatments for hair loss.

A postmenopausal woman's excess male hormone symptoms improved after her ovaries were removed.

Minoxidil and platelet-rich plasma can help turn thin hair into thicker hair in male pattern baldness.

Finasteride was more effective than hydroxychloroquine in treating frontal fibrosing alopecia.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Women with frontal fibrosing alopecia have similar vitamin D levels to those with other hair loss types, suggesting vitamin D is not a key factor in this condition.

A woman's hair loss was initially misdiagnosed as scarring hair loss but was actually a treatable autoimmune hair loss.

Laser treatment may help with hair growth in some people with frontal fibrosing alopecia, but results vary and the exact way it works is unclear.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Female pattern hair loss is different from male pattern hair loss and has unclear genetic causes.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Stress may trigger hair loss by affecting immune protection in hair follicles.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Both vertical and transverse sections are useful for diagnosing alopecia, but using both methods together is best.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

The HairCheck® device is effective for measuring hair loss and growth in people with alopecia.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.